2025 was a milestone year for Viasonix.
We achieved the highest annual sales and revenue in our history, driven by strong worldwide demand for our Falcon vascular physiologic systems and Dolphin transcranial Doppler (TCD) product line.
As a focused medical device manufacturer, we specialize in high‑end vascular physiologic systems, advanced transcranial Doppler equipment, and home care solutions that support clinicians across vascular, neurology, neurosurgery, and related fields. Our 2025 results confirm that this focus continues to deliver value to customers and patients around the world.
2025: Another Record‑Breaking Year
For more than a decade, Viasonix has delivered steady, year‑over‑year sales growth. Each year has set a new internal record, and 2025 was no exception.
After a strong jump in sales in 2024, momentum continued in 2025, with both sales and revenue reaching an all‑time high. This performance reflects growing trust in our technology from hospitals, private clinics, and diagnostic centers worldwide.
In addition, our solid profitability gives us the ability to keep investing where it matters most:
- Ongoing innovation and new product development across the Viasonix product portfolio
- Continuous improvement of our legacy Falcon and Dolphin systems
- Stronger clinical, application, and service support for our customers and distributors
This financial strength also provides long‑term stability for our partners. When a medical center chooses Viasonix, they know we will be there to support them with upgrades, training, and future generations of vascular and TCD solutions.
Falcon Product Line: Complete Peripheral Vascular Diagnosis
Two core product lines are at the heart of Viasonix growth: the Falcon peripheral vascular diagnostic systems and the Dolphin transcranial Doppler machines.
The Falcon vascular physiologic product line is a complete solution for physiologic peripheral vascular diagnosis. Falcon supports key tests such as segmental blood pressures, Ankle Brachial Index (ABI), Toe Brachial Index (TBI), Doppler, pulse volume recording (PVR), photoplethysmography (PPG), and various stress and specialty tests.
Within the Falcon family, customers can select the model that best matches their clinical needs and workflow:
- Falcon/PRO – the high‑end vascular system for advanced physiologic diagnostics in busy vascular laboratories and hospitals.
- Falcon/QUAD – a cost‑effective, 4‑channel vascular system designed for routine day‑to‑day work and rapid ABI and TBI examinations.
- Falcon/ABI+ – a compact system without Doppler, ideal for clinics and practices that focus on rapid vascular screening using ABI, TBI, and PVR. Learn more in the Falcon product line overview.
- Falcon/Xpress – A revolutionary low-cost high-performance device with complete Falcon capabilities.
The Falcon systems are supported by an advanced user interface, rich reporting, EMR/PACS connectivity, and a wide range of regulatory approvals. As a result, Falcon is used across North America, Latin America, Europe, Asia, and Australia–New Zealand.
For readers who want to dive deeper into clinical use cases, our dedicated sections on Vascular / Angiology clinical applications and Clinical Applications of Viasonix Product Lines describe how Falcon supports day‑to‑day vascular workflows.
Falcon/Xpress: Making Advanced Vascular Testing More Accessible
A key contributor to our 2025 success was the commercial launch of Falcon/Xpress, the newest member of the Falcon family.
Falcon/Xpress was designed to bring high‑end physiologic testing into a compact and cost‑effective form factor. It offers a smart solution for clinics and hospitals that need advanced ABI, TBI, segmental blood pressures, and PVR/PPG testing, but also have to work within tight budget and space constraints.
With CE MDR approval and additional international clearances, Falcon/Xpress is now positioned to expand access to advanced peripheral vascular diagnostics in even more markets. Importantly, it does not compromise on clinical performance or functionality, even as it helps sites manage costs.
As we move into 2026, we plan to further extend the Falcon family with at least two additional models and configurations, offering even more flexibility for different clinical environments.
Dolphin Product Line: Advanced Transcranial Doppler for the Brain
- Dolphin/4D – an all‑in‑one TCD system with advanced capabilities for routine cerebral examinations and complex neurology and neurosurgery cases.
- Dolphin/MAX – a high‑end all‑in‑one TCD system with an integrated rechargeable battery, ideal for ICU and operating room environments.
- Dolphin/IQ – a compact and cost‑effective TCD module, providing the same high‑performance Doppler technology in a modular form factor.
- Dolphin/Xpress – An ideal solution for tight budget customers that still need high Dolphin TCD performance.
- Dolphin/XF – a unique robotic TCD probe that can assist in obtaining bilateral cerebral blood flow velocities in just seconds, designed for fast and stable monitoring.
Global Presence in More Than 50 Countries
Viasonix is honored to support physicians and medical centers across the globe.
With numerous regulatory approvals and a strong network of distributors, our products are now sold in more than 50 countries across all continents. This global reach helps us bring consistent vascular and neuro‑vascular diagnostics to a wide variety of healthcare systems, from large university hospitals to regional clinics.
Falcon peripheral vascular diagnostic systems are widely used in vascular, cardiovascular, angiology, phlebology, and wound care settings, where fast and accurate ABI, TBI, and segmental blood pressure testing are essential for early detection of Peripheral Arterial Disease and other vascular conditions.
Dolphin TCD systems serve neurology, neurosurgery, anesthesia, intensive care units, and stroke centers, where real‑time cerebral blood flow assessment and monitoring have a direct impact on patient outcomes.
Looking Ahead: Innovation Roadmap for 2026 and Beyond
While 2025 marked our best financial performance to date, we view it as a foundation for the next chapter rather than a finish line.
In the near term, we plan to introduce at least two new Viasonix products, including new Falcon configurations and further enhancements to the Dolphin TCD family. These upcoming systems are designed to address specific feedback from our users, simplify workflows, and make advanced diagnostics even more accessible.
At the same time, we will continue to invest in software upgrades, cybersecurity, connectivity, and usability improvements for our installed base. Our goal is to ensure that every Viasonix customer, regardless of when they purchased their system, continues to benefit from our latest innovations.
As we look ahead, our vision is clear: to be the preferred partner for any medical center looking for peripheral vascular diagnostic systems or transcranial Doppler solutions.
Thank You to Our Global Community
None of our 2025 achievements would have been possible without the trust and loyalty of our customers, distributors, and partners.
We are deeply grateful to the physicians, technologists, nurses, and biomedical engineers who rely on Falcon and Dolphin every day to support high‑quality patient care. Your feedback drives our roadmap. Your success is our motivation.
We invite you to follow our latest updates and product announcements in the Viasonix News section, and to reach out if you would like a demo, a clinical discussion, or support in selecting the right configuration for your department.
For more information, please leave us a message via our contact form.
